Abstract
Biotechnology's overall failure to achieve pharma's FIPCO model will, paradoxically, finally drive the industry to profitability.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scarlett, J. Biotechnology's emerging opportunities: Lessons from the Bauhaus. Nat Biotechnol 17 (Suppl 1), BE13–BE15 (1999). https://doi.org/10.1038/4629
Issue Date:
DOI: https://doi.org/10.1038/4629
- Springer Nature America, Inc.